nimodipine and Amelia
nimodipine has been researched along with Amelia in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| AMANO, S | 1 |
| DOHI, S | 1 |
Other Studies
1 other study available for nimodipine and Amelia
| Article | Year |
|---|---|
The pathology of ectromelia-infection, with special reference to the modus of inoculation and the organ-changes.
Topics: Animals; Ectromelia; Ectromelia, Infectious; Humans; Immunity; Mice; Nimodipine; Virus Diseases | 1952 |